WEREWOLF THERAPEUTICS, INC. Current Liabilities
WEREWOLF THERAPEUTICS, INC. (HOWL) had Current Liabilities of $7.86 million as of 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-09-22
- 2026-06-30: Liabilities, Current $7.86M.
- 2026-03-31: Liabilities, Current $38.52M.
- 2025-12-31: Liabilities, Current $36.15M.
- 2025-09-30: Liabilities, Current $17.60M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $7.86M S-4 · filed 2026-09-22 |
| 2026-03-31 | $38.52M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $36.15M S-4 · filed 2026-09-22 |
| 2025-09-30 | $17.60M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $15.17M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $11.67M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $15.18M S-4 · filed 2026-09-22 |
| 2024-09-30 | $12.46M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $11.44M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $21.21M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $19.38M 10-K · filed 2025-03-11 |
| 2023-09-30 | $14.44M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $15.01M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $21.72M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $23.99M 10-K · filed 2024-03-07 |
| 2022-09-30 | $27.80M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $30.37M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $11.03M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $11.87M 10-K · filed 2023-03-23 |
| 2021-09-30 | $7.78M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $7.37M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.41M 10-Q · filed 2021-06-10 |
| 2020-12-31 | $5.28M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |